ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 671,34
1,34%
Dow Jones
39 134,76
0,77%
DAX
18 254,18
1,03%
Brent Oil
85,01
0,37%
Bitcoin
65 132,51
0,25%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Profound Medical Corporation (PROF)

  7. Profound Medical Corporation (PROF) Actualités

PROF Profound Medical Corporation

9,00
0,01 (0,11%)
Après les heures de négociation
Dernière mise à jour : 22:20:32
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Profound Medical Corporation PROF NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,01 0,11% 9,00 22:20:32
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
9,03 8,80 9,09 9,00 8,99
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
14/6/202423:23EDGAR2Form F-X - Appointment of Agent for Service of Process and..
14/6/202423:01EDGAR2Form F-10 - Registration Statement for Securities of certain..
14/6/202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/6/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/5/202423:00GLOBEProfound Medical Annual General Meeting of Shareholders..
15/5/202422:12PRNCAPROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS..
14/5/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/5/202413:30GLOBEProfound Medical Receives U.S. FDA 510(k) Clearance for..
09/5/202422:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/5/202422:05GLOBEProfound Medical Announces First Quarter 2024 Financial..
06/5/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/5/202422:15GLOBEGrowing Body of Clinical Evidence Points to the Potential of..
22/4/202422:15GLOBEProfound Medical to Release First Quarter 2024 Financial..
09/4/202413:45GLOBEProfound Medical to Participate in the 2024 Bloom Burton &..
07/3/202422:05GLOBEProfound Medical Announces Fourth Quarter and Full Year 2023..
04/3/202422:30GLOBEProfound Medical to Participate in Barclays 26th Annual..
27/2/202413:45GLOBEProfound Medical in Collaboration with Siemens Healthineers..
15/2/202422:30GLOBEProfound Medical to Release Fourth Quarter and Full Year..
16/1/202422:30GLOBEProfound Medical Announces Non-Brokered Private Placement
03/1/202422:15GLOBEProfound Medical Announces Preliminary Unaudited Fourth..
28/12/202304:40GLOBEProfound Medical Announces Pricing of US$20 Million Public..
27/12/202322:15GLOBEProfound Medical Announces Proposed Public Offering of..
08/11/202313:45GLOBEProfound Medical to Participate in the Stifel 2023..
03/11/202313:00GLOBEProfound Medical Announces CMS Extension of Temporary ‘Code’..
02/11/202321:05GLOBEProfound Medical Announces Third Quarter 2023 Financial..
19/10/202322:30GLOBEProfound Medical to Release Third Quarter 2023 Financial..
10/10/202322:30GLOBEProfound Medical 2023 Virtual Analyst & Investor Day Agenda
25/9/202322:05GLOBEProfound Medical Receives U.S. FDA 510(k) Clearance for..
21/9/202314:00GLOBESave the Date: Profound Medical to Host Virtual Analyst &..
19/9/202322:45GLOBEProfound Medical to Participate in the 2023 Cantor Global..
07/9/202301:23GLOBEProfound Medical Announces At-the-Market Offering of up to..
09/8/202322:05GLOBEProfound Medical Announces Second Quarter 2023 Financial..
02/8/202322:30GLOBEProfound Medical to Release Second Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
PROF
Profound Medical
UNSW3
SWAPETH
TrustSwap Token
EU
SGSG1
Euronext G Saint Gobain ...
GDAX
OPUSD
Optimism
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés